Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the impact of restructuring at the Medicines and Healthcare products Regulatory Agency on that agency's performance in 2022-23.
The Department holds the Medicines and Healthcare products Regulatory Agency (MHRA) to account for their work, including their performance and the impact of any organisational changes, through regular established mechanisms including quarterly and annual accountability reviews. The minutes of the latest Annual Accountability Review with the MHRA are available at the following link: